Robert Warren

1.2k total citations
21 papers, 873 citations indexed

About

Robert Warren is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Robert Warren has authored 21 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Genetics and 4 papers in Cancer Research. Recurrent topics in Robert Warren's work include HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and BRCA gene mutations in cancer (4 papers). Robert Warren is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and BRCA gene mutations in cancer (4 papers). Robert Warren collaborates with scholars based in United States and Italy. Robert Warren's co-authors include Karen Huff, Richard H. Simon, Linda K. Green, Audrey Barlock, Susan C. Aitken, Joseph C. Allegra, Claudine Isaacs, Marc E. Lippman, E. Brad Thompson and Mary Wilkinson and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Robert Warren

21 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Warren United States 13 560 384 200 185 159 21 873
Henrik Hellborg Sweden 18 667 1.2× 355 0.9× 116 0.6× 293 1.6× 337 2.1× 24 1.2k
Roberta Maltoni Italy 21 722 1.3× 376 1.0× 129 0.6× 299 1.6× 338 2.1× 84 1.2k
Amy Tiersten United States 20 1.0k 1.8× 275 0.7× 136 0.7× 324 1.8× 264 1.7× 101 1.6k
Fernando Lara-Medina Mexico 17 487 0.9× 411 1.1× 159 0.8× 198 1.1× 201 1.3× 40 906
Simon J. Hollingsworth United Kingdom 16 351 0.6× 224 0.6× 93 0.5× 153 0.8× 350 2.2× 56 951
R.D. Gelber Switzerland 18 550 1.0× 403 1.0× 231 1.2× 147 0.8× 129 0.8× 31 1.0k
Gianni Amunni Italy 20 358 0.6× 175 0.5× 110 0.6× 224 1.2× 261 1.6× 55 1.2k
A. Goldhirsch Italy 15 537 1.0× 382 1.0× 115 0.6× 143 0.8× 135 0.8× 39 825
Cynthia Osborne United States 9 1.0k 1.8× 432 1.1× 233 1.2× 282 1.5× 441 2.8× 12 1.5k
Mary Cianfrocca United States 14 869 1.6× 533 1.4× 154 0.8× 239 1.3× 232 1.5× 31 1.3k

Countries citing papers authored by Robert Warren

Since Specialization
Citations

This map shows the geographic impact of Robert Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Warren more than expected).

Fields of papers citing papers by Robert Warren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Warren. The network helps show where Robert Warren may publish in the future.

Co-authorship network of co-authors of Robert Warren

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Warren. A scholar is included among the top collaborators of Robert Warren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Warren. Robert Warren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pohlmann, Paula R., Deena Graham, Yvonne Ottaviano, et al.. (2022). HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane. Breast Cancer Research and Treatment. 196(3). 571–581. 4 indexed citations
2.
Khoury, Katia, Filipa Lynce, Ana Barac, et al.. (2021). Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function. Breast Cancer Research and Treatment. 185(3). 863–868. 20 indexed citations
3.
Lynce, Filipa, Matthew Blackburn, Christopher Gallagher, et al.. (2021). Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. Cancer. 127(19). 3622–3630. 14 indexed citations
4.
He, Wei, Karen Dubbin, Aimy Sebastian, et al.. (2021). Abstract 2638: Developing 3d hydrogel model for patient-derived organoids of metastatic colorectal cancer. Cancer Research. 81(13_Supplement). 2638–2638. 1 indexed citations
5.
Lynce, Filipa, Ana Barac, Xue Geng, et al.. (2018). SAFE-HEaRt: A pilot study assessing the cardiac safety of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function.. Journal of Clinical Oncology. 36(15_suppl). 1038–1038. 7 indexed citations
6.
Barac, Ana, Filipa Lynce, Karen L. Smith, et al.. (2016). Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. Breast Cancer Research and Treatment. 155(2). 285–293. 16 indexed citations
7.
Gatti‐Mays, Margaret E., David Venzon, Andrea Singer, et al.. (2016). Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and Safety. Cancer Prevention Research. 9(3). 225–233. 8 indexed citations
8.
Isaacs, Claudine, Pia Herbolsheimer, Minetta C. Liu, et al.. (2010). Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer. Breast Cancer Research and Treatment. 125(1). 137–143. 29 indexed citations
9.
Harless, William G., et al.. (2009). Evaluation of a virtual dialogue method for breast cancer patient education. Patient Education and Counseling. 76(2). 189–195. 24 indexed citations
10.
Liu, Minetta C., Peter G. Shields, Robert Warren, et al.. (2009). Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer. Journal of Clinical Oncology. 27(31). 5153–5159. 257 indexed citations
11.
Warren, Anne Y., et al.. (2006). Breaking Down Barriers to Breast and Cervical Cancer Screening: A University-based Prevention Program for Latinas. Journal of Health Care for the Poor and Underserved. 17(3). 512–521. 21 indexed citations
12.
Stearns, Vered, Ann Gallagher, Celina G. Kleer, et al.. (2004). A Pilot Study to Establish a Clinical Model to Perform Phase II Studies of Breast Cancer Chemopreventive Agents in Women at High Risk with Biomarkers as Surrogate Endpoints for Activity. Clinical Cancer Research. 10(24). 8332–8340. 7 indexed citations
13.
Allegra, Joseph C., Marc E. Lippman, E. Brad Thompson, et al.. (1980). Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer. European Journal of Cancer (1965). 16(3). 323–331. 118 indexed citations
14.
Warren, Robert, et al.. (1978). Membrane transport of methotrexate in human lymphoblastoid cells.. PubMed. 38(3). 668–71. 46 indexed citations
15.
Lippman, Marc E., Joseph C. Allegra, E. Brad Thompson, et al.. (1978). The Relation between Estrogen Receptors and Response Rate to Cytotoxic Chemotherapy in Metastatic Breast Cancer. New England Journal of Medicine. 298(22). 1223–1228. 218 indexed citations
16.
Warren, Robert, Richard A. Bender, Larry Norton, & Robert C. Young. (1978). The treatment of combination chemotherapy‐resistant Hodgkin disease with single‐agent vinblastine. American Journal of Hematology. 4(1). 47–55. 8 indexed citations
17.
Warren, Robert, et al.. (1977). The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(9). 2993–7. 17 indexed citations
18.
Levenson, Stanley Μ., et al.. (1976). Abnormal Pulmonary Gallium Accumulation inP. CariniiPneumonia. Radiology. 119(2). 395–398. 34 indexed citations
19.
Warren, Robert. (1974). Fatal Overdose of Propoxyphene Napsylate and Aspirin. JAMA. 230(2). 259–259. 7 indexed citations
20.
Sly, R. Michael, et al.. (1973). Objective Assessment for Digital Clubbing in Caucasian, Negro, and Oriental Subjects. CHEST Journal. 64(6). 687–689. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henrik Hellborg Breakdown of academic impact, for papers by Roberta Maltoni Breakdown of academic impact, for papers by Amy Tiersten Breakdown of academic impact, for papers by Fernando Lara-Medina Breakdown of academic impact, for papers by Simon J. Hollingsworth Breakdown of academic impact, for papers by R.D. Gelber Breakdown of academic impact, for papers by Gianni Amunni Breakdown of academic impact, for papers by A. Goldhirsch Breakdown of academic impact, for papers by Cynthia Osborne Breakdown of academic impact, for papers by Mary Cianfrocca
Rankless by CCL
2026